ARJO B logo

Arjo AB (publ) Stock Price

OM:ARJO B Community·SEK 6.8b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author

ARJO B Share Price Performance

SEK 24.90
-7.64 (-23.48%)
SEK 29.75
Fair Value
SEK 24.90
-7.64 (-23.48%)
16.3% undervalued intrinsic discount
SEK 29.75
Fair Value
Price SEK 24.90
AnalystConsensusTarget SEK 29.75
AnalystLowTarget SEK 27.00
AnalystHighTarget SEK 34.00

ARJO B Community Narratives

·
Fair Value SEK 29.75 16.3% undervalued intrinsic discount

Leadership Changes And Evolving Market Dynamics Will Shape Future Opportunity

0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
·
Fair Value SEK 27 7.8% undervalued intrinsic discount

Cutting Reimbursements And Home Care Shift Will Erode Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value SEK 34 26.8% undervalued intrinsic discount

Connected Care And Aging Trends Will Drive New Global Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
SEK 27
7.8% undervalued intrinsic discount
Revenue
2.87% p.a.
Profit Margin
5.4%
Future PE
14.25x
Price in 2029
SEK 33.3
SEK 29.75
16.3% undervalued intrinsic discount
Revenue
2.65% p.a.
Profit Margin
5.95%
Future PE
14.24x
Price in 2029
SEK 36.98
SEK 34
26.8% undervalued intrinsic discount
Revenue
2.71% p.a.
Profit Margin
6.66%
Future PE
14.49x
Price in 2029
SEK 42.2

Trending Discussion

Updated Narratives

ARJO B logo

ARJO B: Future Upside Will Depend On Stable Margins And Required Yield

Fair Value: SEK 27 7.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ARJO B logo

ARJO B: Revised Assumptions Suggest Fair Value With Moderate Longer Term Upside Potential

Fair Value: SEK 29.75 16.3% undervalued intrinsic discount
8 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ARJO B logo

ARJO B: Improved Margins And Lower Risk Profile Will Support Future Upside

Fair Value: SEK 34 26.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Very undervalued with excellent balance sheet.

2 Risks
4 Rewards

Arjo AB (publ) Key Details

SEK 10.8b

Revenue

SEK 6.3b

Cost of Revenue

SEK 4.6b

Gross Profit

SEK 4.2b

Other Expenses

SEK 351.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 14, 2026
1.29
42.31%
3.24%
52.8%
View Full Analysis

About ARJO B

Founded
1957
Employees
7000
CEO
Andreas Elgaard
WebsiteView website
www.arjo.com

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment and prevention, as well as for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobility, architects and planners, and rehabilitation services, as well as equipment repair and maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.

Recent ARJO B News & Updates

Narrative Update Jun 01

ARJO B: Future Upside Will Depend On Stable Margins And Required Yield

Analysts are maintaining their SEK 27.0 price target for Arjo, citing slightly adjusted assumptions around the discount rate, revenue growth and profit margin, along with a modestly lower future P/E. Taken together, these changes leave their overall valuation view unchanged.

Recent updates

No updates